Annual Total Long Term Liabilities
$28.40 M
-$24.14 M-45.94%
31 December 2023
Summary:
Finch Therapeutics annual total long term liabilities is currently $28.40 million, with the most recent change of -$24.14 million (-45.94%) on 31 December 2023. During the last 3 years, it has fallen by -$221.17 million (-88.62%). FNCH annual total long term liabilities is now -88.62% below its all-time high of $249.57 million, reached on 31 December 2020.FNCH Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$26.89 M
-$660.00 K-2.40%
30 June 2024
Summary:
Finch Therapeutics quarterly total long term liabilities is currently $26.89 million, with the most recent change of -$660.00 thousand (-2.40%) on 30 June 2024. Over the past year, it has dropped by -$1.91 million (-6.62%). FNCH quarterly long term liabilities is now -89.22% below its all-time high of $249.57 million, reached on 31 December 2020.FNCH Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FNCH Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.9% | -6.6% |
| 3 y3 years | -88.6% | +521.6% |
| 5 y5 years | - | - |
FNCH Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -88.6% | +239.9% | -50.2% | +521.6% |
| 5 y | 5 years | -88.6% | +239.9% | -89.2% | +521.6% |
| alltime | all time | -88.6% | +239.9% | -89.2% | +521.6% |
Finch Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $26.89 M(-2.4%) |
| Mar 2024 | - | $27.55 M(-3.0%) |
| Dec 2023 | $28.40 M(-45.9%) | $28.40 M(-1.4%) |
| Sept 2023 | - | $28.80 M(-2.0%) |
| June 2023 | - | $29.39 M(-10.6%) |
| Mar 2023 | - | $32.88 M(-37.4%) |
| Dec 2022 | $52.54 M | $52.54 M(-1.4%) |
| Sept 2022 | - | $53.29 M(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $54.03 M(+570.7%) |
| Mar 2022 | - | $8.05 M(-3.6%) |
| Dec 2021 | $8.36 M(-96.7%) | $8.36 M(+93.1%) |
| Sept 2021 | - | $4.33 M(-65.7%) |
| June 2021 | - | $12.61 M(-15.9%) |
| Mar 2021 | - | $14.99 M(-94.0%) |
| Dec 2020 | $249.57 M(+60.2%) | $249.57 M |
| Dec 2019 | $155.78 M | - |
FAQ
- What is Finch Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Finch Therapeutics?
- What is Finch Therapeutics annual total long term liabilities year-on-year change?
- What is Finch Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Finch Therapeutics?
- What is Finch Therapeutics quarterly long term liabilities year-on-year change?
What is Finch Therapeutics annual total long term liabilities?
The current annual total long term liabilities of FNCH is $28.40 M
What is the all time high annual total long term liabilities for Finch Therapeutics?
Finch Therapeutics all-time high annual total long term liabilities is $249.57 M
What is Finch Therapeutics annual total long term liabilities year-on-year change?
Over the past year, FNCH annual total long term liabilities has changed by -$24.14 M (-45.94%)
What is Finch Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of FNCH is $26.89 M
What is the all time high quarterly long term liabilities for Finch Therapeutics?
Finch Therapeutics all-time high quarterly total long term liabilities is $249.57 M
What is Finch Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, FNCH quarterly total long term liabilities has changed by -$1.91 M (-6.62%)